Life Sciences Innovative Manufacturing Fund

Robin Swann Excerpts

Wednesday 22nd October 2025 Commons Chamber

[Kanishka Narayan]

The talent and ability of people in Northern Ireland are very much at the forefront of our minds, and we want to ensure that everything we are doing to support the life sciences sector is taking a whole-UK approach. I am very happy to write to the hon. and learned Member on his questions about Northern Irish eligibility.

[Robin Swann (South Antrim) (UUP)]

Will the Minister give way?

[Kanishka Narayan]

I will make some progress for now.

The life sciences innovative manufacturing fund directly supports two of the Government’s key missions: to kick-start economic growth and to build an NHS fit for the future. The scheme is projected to attract nearly £4 billion in private investment, creating more than 7,000 jobs and safeguarding more than 5,000 existing ones.

However, the scheme’s impact is not just economic. The pandemic proved that we cannot take our critical supply chains for granted, and supporting the onshoring of life sciences manufacturing through the fund is therefore critical to strengthening our national resilience and preparedness for future health emergencies.

[Robin Swann]

Will the Minister give way?

[Kanishka Narayan]

I will make some progress.

This week we announced the first two grant awards through the scheme, marking a major milestone in the fund’s roll-out. This will unlock substantial private investment, showcasing the UK’s appeal to valuable, globally mobile life sciences manufacturers. As delivery of the scheme progresses, we expect to announce more grant winners in the coming months. Each project supported through the grant will further strengthen health resilience and drive economic growth across all nations and regions in the UK.

[Kanishka Narayan]

My understanding is that these are grant capital investments that the Government will be making, and I am sure we will be looking at the leverage at a whole-fund level. If there are particular requirements at an individual investment level, I am happy to write to the hon. Member on that particular point.

[Robin Swann]

Will the Minister give way?

[Kanishka Narayan]

I feel that, out of parity, I must give way to the hon. Member too.

[Robin Swann]

Third time lucky. I welcome the Minister’s announcement of the fund for life sciences with regard to the companies we have in North Antrim and South Antrim. Could the Minister also ensure that any research and development tax credits that companies can apply for are fully supported, utilised and brought forward at speed so that companies are able to utilise not just the fund but the tax credits that come through R&D as well?

[Kanishka Narayan]

I thank the hon. Member for his important point. I am happy to take a full look at the R&D tax credit system and how it will support our ambitions to back our private sector partners in both R&D and subsequent commercialisation.

The Government are clear that the life sciences innovative manufacturing fund is a strategic investment in our future. It is a vital step in delivering the Government’s commitment to supporting the UK’s life sciences sector and ensuring that our country remains at the forefront of the sector.